MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL

137 Ratings

Rs 13,624 Rs 10,400

24 % OFF

DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) IN ACUTE LYMPHOBLASTIC LEUKEMIA PREDICTS OUTCOME. THIS ASSAY CAN IDENTIFY PATIENTS AT HIGHER/LOWER RISK OF RELAPSE. DETECTION OF MRD IS IMPORTANT FOR RISK ASSESSMENT AND STRATIFICATION OF THERAPY.

Why book with us?

  • Free and On Schedule Sample Collection
  • 24/7 Service
  • Affordable
  • Quick and Accurate Reports

3 ML (1 ML MIN.) FIRST PULL BONE MARROW ASPIRATE IN 1 GREEN TOP (SODIUM HEPARIN) TUBE. SHIP IMMEDIATELY AT 18-22 C. DO NOT FREEZE. IT IS MANDATORY TO PROVIDE DATE & TIME OF SAMPLING, PREVIOUS IMMUNOPHENOTYPE REPORT & CLINICAL HISTORY.

FLOW CYTOMETRY

REPORT ON 4TH DAY EVENING 7PM

IT IS MANDATORY TO PROVIDE DATE & TIME OF SAMPLING, PREVIOUS IMMUNOPHENOTYPE REPORT & CLINICAL HISTORY.

Get a Free Call

To Know about Services Detail or any Enquiry.

book health check